CHMP backs Europe’s first allogeneic stem cell therapy – PMLiVE
PMLiVE |
CHMP backs Europe's first allogeneic stem cell therapy
PMLiVE Belgian biotech TiGenix and partner Takeda have had their stem cell therapy for perianal fistulas in Crohn's disease patients recommended for approval in the EU. The Committee for Medicinal Products for Human Use (CHMP) backed the allogeneic (donor … |
